ASCO 2022 Conference Coverage


 

ASCO 2022 Brexucabtagene Autoleucel for R/R Mantle Cell Lymphoma: Real-World Experience From the United States Lymphoma CAR-T Consortium

87 views
June 15, 2022
Comments 0
Login to view comments. Click here to Login